American Society of Hematology (ASH)/LinkedIn
Apr 15, 2026, 16:53
Sickle Cell Disease Care Varies by Region – ASH
American Society of Hematology (ASH) shared a post on LinkedIn:
”Sickle cell disease is the most common inherited blood disorder worldwide, yet patient experiences vary significantly by region.
Data from the Sickle Cell World Assessment Survey (SWAY) show that individuals in sub-Saharan Africa are less likely to know their sickle cell variant and use standard treatments, including over-the-counter pain medications, antibiotics, and folic acid.
They are also more likely to manage vaso-occlusive crises at home or rely on alternative approaches.
These results reflect variation in diagnosis, treatment patterns, and care delivery across regions.”
Stay updated with Hemostasis Today.
-
May 27, 2026, 04:47Daniel Torrent: The Overlooked Epidemic of Post-Thrombotic Syndrome
-
May 27, 2026, 04:45Graziella Pompei: Is Aspirin Still a Valid Alternative to Clopidogrel in PCI with DES Implantation?
-
May 27, 2026, 04:40Kausik Ray: Phase 1 Trial Highlights Anti-Inflammatory Effects of Ruvonoflast
-
May 27, 2026, 04:29Francisco Chacón-Lozsán: High-Sensitivity Troponin and the Evolving Management of NSTEMI
-
May 27, 2026, 04:14Michael R. Jaff: HI-PEITHO Trial and NEWS Score Insights on Advances for Intermediate-Risk Pulmonary Embolism
-
May 26, 2026, 16:45Ashley George: Take the Leap for Thrombosis UK
-
May 26, 2026, 16:40Hamed Helisaz: Machine Learning for Detecting Missing Heart Medications
-
May 26, 2026, 15:32Haroun Gajraj: Brown Marks After Microsclerotherapy – What Every Practitioner Needs to Know
-
May 26, 2026, 15:29Jacqueline van Paassen: Lack of Essential Clinical Data in DOAC Prescriptions in Community Pharmacies